Mark M. Painter
Impact in
- Infectious Diseases top 0.5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Virology top 5%
- HIV Research and Treatment
Papers in
- Virology 9
- HIV Research and Treatment 9
-
- SARS-CoV-2 and COVID-19 Research 12
- HIV/AIDS drug development and treatment 1
- Co-authors
- Kathleen L. Collins (8 shared papers)E. John Wherry (4 shared papers)Valeri H. Terry (6 shared papers)Ryan P. Staupe (1 shared paper)Jennifer E. Wu (1 shared paper)Xiaowei Xu (1 shared paper)Shin Foong Ngiow (1 shared paper)Josephine Ruth Giles (1 shared paper)
- Journals
- Nature Immunology (5 papers)Cell Reports (3 papers)Journal of Virology (2 papers)Cell (2 papers)Immunity (2 papers)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Mark M. Painter
26 papers receiving 3k citations
Mark M. Painter's Hit Papers
Peers
Comparison fields: 5 of 80
- Infectious Diseases 2.1k
- Virology 145
- Immunology 364
- Pathology and Forensic Medicine 185
- Neurology 149
Countries citing papers authored by Mark M. Painter
This map shows the geographic impact of Mark M. Painter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark M. Painter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark M. Painter more than expected).
Fields of papers citing papers by Mark M. Painter
This network shows the impact of papers produced by Mark M. Painter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark M. Painter. The network helps show where Mark M. Painter may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark M. Painter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern Hit paper breakdown → | 2021 | 682 |
| 2 | Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccination Hit paper breakdown → | 2021 | 514 |
| 3 | Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy Hit paper breakdown → | 2021 | 422 |
| 4 | Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination Hit paper breakdown → | 2021 | 392 |
| 5 | SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC) Hit paper breakdown → | 2023 | 194 |
| 6 | 2022 | 177 | |
| 7 | Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine Hit paper breakdown → | 2022 | 163 |
| 8 | 2022 | 140 | |
| 9 | 2023 | 70 | |
| 10 | Immunological imprinting shapes the specificity of human antibody responses against SARS-CoV-2 variants Hit paper breakdown → | 2024 | 52 |
| 11 | 2018 | 49 | |
| 12 | 2018 | 37 | |
| 13 | 2020 | 28 | |
| 14 | 2022 | 28 | |
| 15 | 2025 | 20 | |
| 16 | 2017 | 19 | |
| 17 | 2020 | 17 | |
| 18 | 2022 | 17 | |
| 19 | 2022 | 17 | |
| 20 | 2025 | 6 |
About Mark M. Painter
Mark M. Painter is a scholar working on Virology, Infectious Diseases, Neurology, Immunology and Biophysics, having authored 29 papers that have together received 3.1k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (12 papers), HIV Research and Treatment (9 papers), Single-cell and spatial transcriptomics (3 papers), T-cell and B-cell Immunology (2 papers), Long-Term Effects of COVID-19 (2 papers), Cancer Immunotherapy and Biomarkers (1 paper), Virus-based gene therapy research (1 paper) and HIV/AIDS drug development and treatment (1 paper). The work is most often cited by research in Infectious Diseases (2.1k citations), Virology (145 citations), Immunology (364 citations), Pathology and Forensic Medicine (185 citations) and Neurology (149 citations). Mark M. Painter has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Kathleen L. Collins, E. John Wherry, Valeri H. Terry, Ryan P. Staupe, Jennifer E. Wu, Xiaowei Xu, Shin Foong Ngiow, Josephine Ruth Giles, Tara C. Mitchell and Mohamed S. Abdel-Hakeem. Their work appears in journals such as Nature Immunology, Cell Reports, Journal of Virology, Cell and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.